HLNE Stock Recent News

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 1,572,536 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations.

The Fund features a high-quality venture portfolio targeting top-performing, oversubscribed funds and companies CONSHOHOCKEN, Pa. , Feb. 6, 2025 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the final close of its Venture Access Fund ("VAF" or "the Fund"), which successfully exceeded its target fund size, raising $615.3 million in commitments.

Hamilton Lane Incorporated (NASDAQ:HLNE ) Q3 2025 Earnings Conference Call February 4, 2025 11:00 AM ET Company Participants John Oh - Head of Shareholder Relations Erik Hirsch - Co-CEO Jeff Armbrister - CFO Conference Call Participants Ken Worthington - JPMorgan Alex Blostein - Goldman Sachs Michael Cyprys - Morgan Stanley Mike Brown - Wells Fargo Aidan Hall - KBW Operator Good morning, ladies and gentlemen, and welcome to the Hamilton Lane Fiscal Third Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.

The headline numbers for Hamilton Lane (HLNE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Hamilton Lane (HLNE) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.71 per share a year ago.

CONSHOHOCKEN, Pa. , Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the third fiscal quarter ended December 31, 2024.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #commercial--Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. “Cosette is in the midst of an exciting period of accelerated growth and portfolio e.

Annual global report, surveying more than 300 investment advisors, finds diversification and performance continue to drive private wealth interest in the asset class Private infrastructure is poised to gain market share, with 48% of those surveyed planning to increase exposure in that sector Despite interest, many investors have only "beginner" knowledge of the asset class, highlighting importance of ongoing education as well as opportunity to deepen client relationships  CONSHOHOCKEN, Pa. , Jan. 29, 2025 /PRNewswire/ -- Private market allocations are rapidly becoming a significant portion of advisors' book of business, according to a recent survey of investment advisors conducted by global private markets investment management firm Hamilton Lane (Nasdaq: HLNE).

CONSHOHOCKEN, Pa. , Jan. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the third fiscal quarter before the market opens on Tuesday, February 4, 2025.